ATE381929T1 - Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe - Google Patents
Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippeInfo
- Publication number
- ATE381929T1 ATE381929T1 AT03772659T AT03772659T ATE381929T1 AT E381929 T1 ATE381929 T1 AT E381929T1 AT 03772659 T AT03772659 T AT 03772659T AT 03772659 T AT03772659 T AT 03772659T AT E381929 T1 ATE381929 T1 AT E381929T1
- Authority
- AT
- Austria
- Prior art keywords
- resveratrol
- flu
- treatment
- production
- medicinal product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000562A ITRM20020562A1 (it) | 2002-11-06 | 2002-11-06 | Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE381929T1 true ATE381929T1 (de) | 2008-01-15 |
Family
ID=32310188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03772659T ATE381929T1 (de) | 2002-11-06 | 2003-10-14 | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8431617B2 (de) |
| EP (1) | EP1567137B1 (de) |
| JP (1) | JP4589118B2 (de) |
| KR (1) | KR101060331B1 (de) |
| AR (1) | AR041891A1 (de) |
| AT (1) | ATE381929T1 (de) |
| AU (1) | AU2003279551A1 (de) |
| CA (1) | CA2504872C (de) |
| CY (1) | CY1107302T1 (de) |
| DE (1) | DE60318327T2 (de) |
| DK (1) | DK1567137T3 (de) |
| ES (1) | ES2295660T3 (de) |
| IT (1) | ITRM20020562A1 (de) |
| MX (1) | MXPA05004628A (de) |
| PL (1) | PL217628B1 (de) |
| PT (1) | PT1567137E (de) |
| TW (1) | TWI337863B (de) |
| WO (1) | WO2004041260A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1951285A2 (de) * | 2005-11-18 | 2008-08-06 | Ares Trading S.A. | Interferon bei grippe |
| EP2268272A2 (de) * | 2008-03-06 | 2011-01-05 | Mount Sinai School of Medicine of New York University | Verbindungen zur modulation der replikation von einstrangigen minus-rna-viren und verwendungen davon |
| WO2010053949A1 (en) * | 2008-11-04 | 2010-05-14 | Metaproteomics, Llc | Phytochemical compositions and methods for activating amp-kinase |
| US20110236349A1 (en) * | 2008-12-19 | 2011-09-29 | Koff Jonathan L | Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection |
| KR100950445B1 (ko) | 2009-10-26 | 2010-04-02 | 주식회사 중앙백신연구소 | 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제 |
| WO2011150413A1 (en) | 2010-05-28 | 2011-12-01 | Mount Sinai School Of Medicine | Antiviral compounds and uses thereof |
| US9453017B2 (en) * | 2011-09-30 | 2016-09-27 | Vanderbilt University | Antiviral therapies with phospholipase D inhibitors |
| PT2952209T (pt) | 2014-06-04 | 2018-05-09 | Alfasigma Spa | Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral |
| PL2952180T3 (pl) | 2014-06-04 | 2017-05-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | STAŁE FORMULACJE ZAWIERAJĄCE RESWERATROL I WIELONIENASYCONE KWASY TŁUSZCZOWE OMEGA-3 (n-3 PUFA) |
| EP3120842A1 (de) | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneale therapeutische flüssigkeit |
| KR20170039456A (ko) | 2015-10-01 | 2017-04-11 | 동아대학교 산학협력단 | 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물 |
| JP2018024592A (ja) * | 2016-08-09 | 2018-02-15 | 株式会社ブレインヘルス | 抗生物質含有組成物 |
| CN108893558B (zh) * | 2018-05-24 | 2022-04-05 | 江苏海宏制药有限公司 | 一种桑木液原液抗病毒实验方法以及装置 |
| WO2021207094A1 (en) * | 2020-04-05 | 2021-10-14 | Mong Michael | Systems and methods for treating coronavirus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2778337B1 (fr) * | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | Antagonistes des ligands du recepteur des arylhydrocarbures |
| PE20010540A1 (es) * | 1999-07-30 | 2001-05-15 | Procter & Gamble | Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza |
| WO2001012228A2 (en) | 1999-08-13 | 2001-02-22 | University Of Maryland Biotechnology Institute | Compositions for treating viral infections, and methods therefor |
-
2002
- 2002-11-06 IT IT000562A patent/ITRM20020562A1/it unknown
-
2003
- 2003-10-14 US US10/533,942 patent/US8431617B2/en active Active
- 2003-10-14 ES ES03772659T patent/ES2295660T3/es not_active Expired - Lifetime
- 2003-10-14 JP JP2004549541A patent/JP4589118B2/ja not_active Expired - Lifetime
- 2003-10-14 PL PL377557A patent/PL217628B1/pl unknown
- 2003-10-14 KR KR1020057007230A patent/KR101060331B1/ko active IP Right Grant
- 2003-10-14 AT AT03772659T patent/ATE381929T1/de active
- 2003-10-14 PT PT03772659T patent/PT1567137E/pt unknown
- 2003-10-14 EP EP03772659A patent/EP1567137B1/de not_active Expired - Lifetime
- 2003-10-14 MX MXPA05004628A patent/MXPA05004628A/es active IP Right Grant
- 2003-10-14 AU AU2003279551A patent/AU2003279551A1/en not_active Abandoned
- 2003-10-14 DE DE60318327T patent/DE60318327T2/de not_active Expired - Lifetime
- 2003-10-14 WO PCT/IT2003/000626 patent/WO2004041260A1/en active IP Right Grant
- 2003-10-14 CA CA2504872A patent/CA2504872C/en not_active Expired - Lifetime
- 2003-10-14 DK DK03772659T patent/DK1567137T3/da active
- 2003-10-27 TW TW092129780A patent/TWI337863B/zh not_active IP Right Cessation
- 2003-11-05 AR ARP030104047A patent/AR041891A1/es unknown
-
2008
- 2008-03-12 CY CY20081100281T patent/CY1107302T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI337863B (en) | 2011-03-01 |
| KR101060331B1 (ko) | 2011-08-30 |
| DK1567137T3 (da) | 2008-04-28 |
| AU2003279551A1 (en) | 2004-06-07 |
| PL217628B1 (pl) | 2014-08-29 |
| TW200501935A (en) | 2005-01-16 |
| JP2006507295A (ja) | 2006-03-02 |
| PL377557A1 (pl) | 2006-02-06 |
| DE60318327T2 (de) | 2008-12-18 |
| PT1567137E (pt) | 2008-02-19 |
| EP1567137B1 (de) | 2007-12-26 |
| US8431617B2 (en) | 2013-04-30 |
| MXPA05004628A (es) | 2005-09-08 |
| CA2504872A1 (en) | 2004-05-21 |
| AR041891A1 (es) | 2005-06-01 |
| ITRM20020562A1 (it) | 2004-05-07 |
| ES2295660T3 (es) | 2008-04-16 |
| JP4589118B2 (ja) | 2010-12-01 |
| WO2004041260A1 (en) | 2004-05-21 |
| KR20050071627A (ko) | 2005-07-07 |
| CY1107302T1 (el) | 2012-11-21 |
| EP1567137A1 (de) | 2005-08-31 |
| US20050239906A1 (en) | 2005-10-27 |
| DE60318327D1 (de) | 2008-02-07 |
| CA2504872C (en) | 2011-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| ATE512661T1 (de) | Verwendung eines betablockers zur herstellung eines arzneimittels zur behandlung von hämangiomen | |
| ATE381929T1 (de) | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe | |
| DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| FR2838048B1 (fr) | Produit dentaire reticulable/dereticulable | |
| DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
| EP1687733A4 (de) | System und prozess zur ermöglichung der bereitstellung von gesundheitsversorgung | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| DE60318785D1 (de) | Methode zur Herstellung von halbleitenden Nanopartikeln | |
| SE0303571D0 (sv) | Medical product for moisture-sensitive medicaments | |
| ATE384699T1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
| DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| ATE465990T1 (de) | Arylalkylcarbamatderivate, verfahren zur ihrer herstellung und deren therapeutischen anwendungen | |
| ATE389742T1 (de) | Gewebebehandlungsmittel | |
| PL1608811T3 (pl) | Wyrób wielowarstwowy i sposób jego wytwarzania | |
| DE602004014805D1 (de) | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten | |
| DE60230455D1 (de) | Natürliche verbindung für die behandlung von diabetes, deren herstellung und verwendung | |
| SE0303400L (sv) | Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår | |
| ATE543818T1 (de) | -n(2-hydroxyethyl)-n-methyl-4-(chinolin-8-yl-(1 (thiazol-4-ylmethyl)piperidin-4- yliden)methyl)benzamid, verfahren zu dessen herstellung sowie dessen verwendung zur behandlung von schmerzen, angst und depression | |
| DE60305400D1 (de) | Anlage zur Behandlung von Produkten und dazugehörige Datenerfassungseinheit | |
| DE502004004324D1 (de) | Maschine zur Behandlung eines Gleises | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| DE60220837D1 (de) | Sterilisator und sterilisationsverfahren | |
| ATE527997T1 (de) | Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1567137 Country of ref document: EP |